Health Care

Vice President Harris released part of her economic agenda aimed at lowering costs for families, which the nonpartisan CRFB estimates would add $1.7 trillion to the national debt.

California legislators are trying to pass a bill that would require warning labels be placed on gas stoves, alerting customers about potential health risks associated with the products.

More than 100 illnesses, including over 40 hospitalizations, have been linked to the Diamond Shruumz-branded chocolate bars, cones or gummies that were recalled in June.

The deaths and illnesses related to the multi-state outbreak of listeria continues to grow. Officials have tied to the outbreak to deli meats, including from Boar's Head.

Eli Lilly and Co. reported strong second-quarter results, beating Wall Street estimates and prompting the company to raise its full-year revenue forecast by $3 billion.

Danish drug maker Novo Nordisk lowered its full year forecast even as tens of thousands of patients start the highly coveted weight loss drug, Wegovy, every week.

CVS said Wednesday that it's launching a multi-year productivity initiative. It also cut its outlook for the year as its health care benefits segment continues to face pressure.

Pharmaceutical giant Roche is "fast-tracking" its own weight-loss pills in clinical trials as it looks to compete with Novo Nordisk's Wegovy and Eli Lilly's Zepbound.

Cinnamon that's been shipped to retailers in four states is being recalled after testing revealed elevated levels of lead. Long-term exposure to lead can be harmful to adults and kids.

Wiers Farm Inc. is expanding its recall for bagged vegetables and salad over concerns that the products could be contaminated with listeria, according to the notice posted by the FDA.

Per- and polyfluoroalkyl substances, otherwise known as "forever chemicals," are man-made chemicals that can be found in many everyday products. Here's what you need to know.

The health care industry is dealing with increased attacks by cybercriminals. A cybersecurity expert said the rise is linked to the value of personal information that could be stolen.

Pfizer announced that it is advancing its oral weight-loss treatment, called danuglipron, to the next round in an ongoing study after seeing "encouraging" results.

Non-alcoholic spirt mixes are being recalled after officials said they were produced in a facility that was not licensed or inspected.